Russell Goldsmith serves as co-chair of Symbiotic Capital, a new Los Angeles-based credit platform. Organization, location and related investors we track.
Russell Goldsmith serves as co-chair of Symbiotic Capital, a new Los Angeles-based credit platform that launched with over $600 million in committed capital dedicated to life science financing. He previously ran City National Bank as its chairman and CEO, bringing extensive financial leadership to the firm’s science committee alongside experts like Dr. Fran Schumer and Dr. Toby Cosgrove. Symbiotic Capital’s investment thesis targets late-stage, mature life science companies that are either commercializing products or in late development for drugs, diagnostics, or devices across all subsectors including synthetic biology and healthcare IT. The firm provides non-dilutive senior secure term loans with a four-to-five-year horizon, structured to allow conversion of part of the loan into equity, rather than making traditional venture equity checks. While specific check sizes and lead/follow behavior are not publicly detailed, the firm focuses on established companies capable of repaying loans, indicating a credit-first rather than pure venture capital approach. Notable portfolio companies are not explicitly named in available sources, though the firm’s manda
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Los Angeles.
Investors like Russell Goldsmith · Full investor directory · Investor access · Company funding database